{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:38:21Z","timestamp":1790105901433,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"USPHS NIH","award":["U01AI060592"],"award-info":[{"award-number":["U01AI060592"]}]},{"name":"USPHS NIH","award":["RO1AI10085"],"award-info":[{"award-number":["RO1AI10085"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.vaccine.2013.01.019","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T04:15:16Z","timestamp":1359605716000},"page":"1576-1581","source":"Crossref","is-referenced-by-count":86,"title":["Potential coverage of a multivalent M protein-based group A streptococcal vaccine"],"prefix":"10.1016","volume":"31","author":[{"given":"James B.","family":"Dale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Penfound","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubou","family":"Tamboura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samba O.","family":"Sow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Nataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagritos","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Kotloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2013.01.019_bib0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.01.019_bib0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa065085","article-title":"Prevalence of rheumatic heart disease detected by echocardiographic screening","volume":"357","author":"Marijon","year":"2007","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2013.01.019_bib0015","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.amjcard.2010.01.364","article-title":"Prevalence of rheumatic heart disease in children and young adults in Nicaragua","volume":"105","author":"Paar","year":"2010","journal-title":"Am J Card"},{"issue":"25","key":"10.1016\/j.vaccine.2013.01.019_bib0020","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1161\/CIRCULATIONAHA.112.092312","article-title":"Echocardiography screening for rheumatic heart disease in Ugandan school children","volume":"125","author":"Beaton","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.019_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-3156.2010.02670.x","article-title":"Systematic review: estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis","volume":"16","author":"Jackson","year":"2011","journal-title":"Trop Med Int Health"},{"issue":"10","key":"10.1016\/j.vaccine.2013.01.019_bib0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm-type distribution of group A streptococci: systematic review and implications for vaccine development","volume":"9","author":"Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.01.019_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-0-387-73960-1_5","article-title":"Current status of group A streptococcal vaccine development","volume":"609","author":"Dale","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2013.01.019_bib0040","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine","volume":"70","author":"Hu","year":"2002","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2013.01.019_bib0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"46","key":"10.1016\/j.vaccine.2013.01.019_bib0050","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.01.019_bib0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of the type specific M antigens of group A streptococci","volume":"89","author":"Lancefield","year":"1962","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.01.019_bib0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.110.2.271","article-title":"Persistence of type-specific antibodies in man following infection with group A streptococci","volume":"110","author":"Lancefield","year":"1959","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.01.019_bib0065","series-title":"The epidemiology of streptococcal infection","author":"Wannamaker","year":"1954"},{"issue":"3","key":"10.1016\/j.vaccine.2013.01.019_bib0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/421949","article-title":"Group A streptococcal pharyngitis serotype surveillance in North America, 2000\u20132002","volume":"39","author":"Shulman","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.019_bib0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/599344","article-title":"Seven-year surveillance of North American pediatric group a streptococcal pharyngitis isolates","volume":"49","author":"Shulman","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2013.01.019_bib0080","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000\u20132004","volume":"45","author":"O\u2018Loughlin","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.01.019_bib0085","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1128\/JCM.02155-08","article-title":"Clinical and microbiological characteristics of severe streptococcus pyogenes disease in Europe","volume":"47","author":"Luca-Harari","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.01.019_bib0090","unstructured":"Tapia M, Sow SO, Tamboura B, Nataro JP, Penfound TA, Dale JB, et al. Molecular epidemiology of streptococcal pharyngitis in Bamako, Mali; unpublished results."},{"issue":"4","key":"10.1016\/j.vaccine.2013.01.019_bib0095","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/JCM.34.4.953-958.1996","article-title":"Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci","volume":"34","author":"Beall","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.01.019_bib0100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1084\/jem.106.4.525","article-title":"Differentiation of group A streptococci with a common R antigen into three serologic types with special reference to the bactericidal test","volume":"106","author":"Lancefield","year":"1957","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.01.019_bib0105","unstructured":"Swiss Institute of Bioinformatics SIM Alignment Program. Available from: http:\/\/web.expasy.org\/sim [cited 23.8.2012]."},{"key":"10.1016\/j.vaccine.2013.01.019_bib0110","unstructured":"CDC Streptococcal Reference Page [cited August 23, 2012]. Available from: ftp:\/\/ftp.cdc.gov\/pub\/infectious_diseases\/biotech\/tstransl\/."},{"issue":"31","key":"10.1016\/j.vaccine.2013.01.019_bib0115","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1016\/j.vaccine.2010.05.018","article-title":"Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes","volume":"28","author":"Penfound","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.01.019_bib0120","doi-asserted-by":"crossref","unstructured":"Dale JB, Fischetti VA, Carapetis JR, Steer AC, Sow SO, Kumar R, et al. Group A streptococcal vaccines: paving a path for accelerated development. Vaccine; in press.","DOI":"10.1016\/j.vaccine.2012.09.045"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T22:42:22Z","timestamp":1687992142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0264410X13000765"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.01.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}